Drug Information
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Epidermal growth factor receptor (EGFR) | Target Info | Modulator | [1] |
| Erbb2 tyrosine kinase receptor (HER2) | Target Info | Modulator | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma. Clin Cancer Res. 2015 Apr 1;21(7):1566-73. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.